Evidence map›Paper›PMID 37502244›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2023

Time to change the way we think about tuberculosis infection prevention and control in health facilities: insights from recent research.

Tom A Yates, Aaron S Karat, Fiammetta Bozzani, Nicky McCreesh, Hayley MacGregor, Peter G Beckwith, Indira Govender, Christopher J Colvin, Karina Kielmann, Alison D Grant

Abstract readEditorial
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Impact of indoor ventilation on TB transmission risk: implications of climate change.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tom A YatesDivision of Infection and Immunity, Faculty of Medicine, University College London, London, UK.ORCID https://orcid.org/0000-0002-6081-1767
Aaron S KaratTB Centre, London School of Hygiene & Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0001-9643-664X
Fiammetta BozzaniTB Centre, London School of Hygiene & Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0002-9518-6885
Nicky McCreeshTB Centre, London School of Hygiene & Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0003-1409-8531
Hayley MacGregorThe Institute of Development Studies, University of Sussex, Brighton, UK.ORCID https://orcid.org/0000-0002-9392-9331
Peter G BeckwithDepartment of Medicine, University of Cape Town, Rondebosch, South Africa.ORCID https://orcid.org/0000-0003-3206-5696
Indira GovenderTB Centre, London School of Hygiene & Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0003-0598-7388
Christopher J ColvinDivision of Social and Behavioural Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-8930-7863
Karina Kielmann *The Institute for Global Health and Development, Queen Margaret University, Musselburgh, UK.ORCID https://orcid.org/0000-0001-5519-1658
Alison D GrantTB Centre, London School of Hygiene & Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0002-2437-5195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In clinical settings where airborne pathogens, such as Mycobacterium tuberculosis, are prevalent, they constitute an important threat to health workers and people accessing healthcare. We report key insights from a 3-year project conducted in primary healthcare clinics in South Africa, alongside other recent tuberculosis infection prevention and control (TB-IPC) research. We discuss the fragmentation of TB-IPC policies and budgets; the characteristics of individuals attending clinics with prevalent pulmonary tuberculosis; clinic congestion and patient flow; clinic design and natural ventilation; and the facility-level determinants of the implementation (or not) of TB-IPC interventions. We present modeling studies that describe the contribution of M. tuberculosis transmission in clinics to the community tuberculosis burden and economic evaluations showing that TB-IPC interventions are highly cost-effective. We argue for a set of changes to TB-IPC, including better coordination of policymaking, clinic decongestion, changes to clinic design and building regulations, and budgeting for enablers to sustain implementation of TB-IPC interventions. Additional research is needed to find the most effective means of improving the implementation of TB-IPC interventions; to develop approaches to screening for prevalent pulmonary tuberculosis that do not rely on symptoms; and to identify groups of patients that can be seen in clinic less frequently.

Identifiers

PMID37502244
PMCPMC10369445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.